Evidence map›Paper›PMID 42244903›Full record

ReviewNanoscale advances2026

Antioxidant and antibacterial properties of transition metals and metal oxides for medical uses: mechanisms, design strategies, and biomedical perspectives.

Iman A Mohammed Ali, Ali Ben Ahmed

Abstract readReview
In one paragraph

Review in Nanoscale advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Iman A Mohammed AliMinistry of Higher Education and Scientific Research Baghdad Iraq.
Ali Ben AhmedUniversity of Sfax, Higher Institute of Biotechnology of Sfax Sfax Tunisia ali.benahmed@isbs.usf.tn.ORCID https://orcid.org/0000-0001-8560-2630

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review provides a critical and integrative analysis of transition metal and metal oxide NPs as emerging multifunctional platforms for biomedical applications, with particular emphasis on their dual antioxidant and antibacterial properties. Beyond conventional descriptive approaches, we systematically correlate physicochemical parameters, including particle size, morphology, surface charge, crystallinity, and functionalization, with biological performance, thereby establishing clear structure-activity relationships governing therapeutic efficacy and biosafety. Key transition metals such as Ag, Cu, Se, Ti, Zn, and Fe, along with their oxides, are examined in terms of their mechanistic pathways, including reactive oxygen species (ROS) modulation, metal ion release, membrane disruption, and enzyme-mimetic antioxidant activity. Recent advances in synthesis strategies, particularly green and bioinspired methods, are highlighted as enabling routes for improving biocompatibility, stability, and targeted functionality. Importantly, this review critically discusses the dual role of ROS in mediating both antibacterial action and oxidative stress regulation, offering a unified framework for designing balanced nano-therapeutics. Comparative analyses reveal that materials with strong antibacterial activity often exhibit weaker intrinsic antioxidant capacity, underscoring the need for rational design of hybrid or multifunctional nanoplatforms. Furthermore, key challenges related to cytotoxicity, long-term biosafety, microbial resistance, and clinical translation are comprehensively evaluated. Strategies such as surface engineering, controlled ion release, and synergistic combinations with conventional antibiotics are proposed to overcome these limitations. By bridging fundamental mechanisms with applied biomedical perspectives, this review provides actionable insights for the next generation of safe, effective, and clinically translatable metal-based nanomaterials.

Identifiers

PMID42244903
PMCPMC13231467

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.